*Department of Radiation Oncology,Sun Yat-sen Univ06ersity Cancer Center,State Key Laboratory of Oncology in South China,Guangzhou 510060,ChinaCorresponding author:Gao Yuanhong,Email:gaoyh@sysucc.org.cn
Abstract Objective To evaluate the efficacy of chemoradiotherapy alone and prognostic factors for locally advanced rectal cancer. Methods The clinical data of 47 patients with locally advanced rectal cancer who were admitted to our hospital and mostly treated with chemoradiotherapy alone from 2003 to 2010 were retrospectively analyzed. Three of the patients received radiotherapy alone. The Kaplan-Meier method was used to estimate overall survival (OS), progression-free survival (PFS), and distant metastasis-free survival (DMFS) rates, and the log-rank test was used for survival difference analysis and univariate prognostic analysis. The Cox regression model was used for multivariate prognostic analysis. Results In all patients, the 3-and 5-year OS rates were 53.2% and 33.2%, respectively, while the 3-and 5-year PFS rates were 37% and 31%, respectively. During the follow-up, 15 patients (32%) had local progression with PFS of 1-60 months (median PFS, 14 months);23 patients (49%) had distant metastasis with DMFS of 2-60 months (median DMFS, 17 months). Patients treated with high-dose radiotherapy had significantly lower 3-and 5-year local progression rates than patients treated with medium-dose radiotherapy (11% vs. 54%;11% vs. 57%;P=0.004). After chemoradiotherapy, 9 patients (19%) had clinical complete response (cCR), and the 3-and 5-year OS and PFS rates in those patients were all 8/9. The univariate analysis indicated that tumor distance from the anus and cCR were influencing factors for prognosis (P=0.026;P=0.000). However, the multivariate analysis showed that cCR was the only influencing factor for survival (HR=12.24;95%CI, 1.64-91.29;P=0.015). Conclusions Chemoradiotherpay or radiotherapy alone is effective and safe in the treatment of patients with locally advanced rectal cancer who have to give up surgery or have unresectable tumors. High-dose radiotherapy may improve local control rate. Complete response to chemoradiotherapy predicts satisfactory treatment outcomes.
Zhang Luning*,You Kaiyun,Huang Rong et al. Chemoradiotherapy for locally advanced rectal cancer:a clinical analysis of 47 patients[J]. Chinese Journal of Radiation Oncology, 2015, 24(5): 521-524.
Zhang Luning*,You Kaiyun,Huang Rong et al. Chemoradiotherapy for locally advanced rectal cancer:a clinical analysis of 47 patients[J]. Chinese Journal of Radiation Oncology, 2015, 24(5): 521-524.
[1] National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology—rectal cancer[DB/OL][2014-10-30].http://www.nccn.org/. [2] Hiotis SP,Weber SM,Cohen AM,et al. Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer:an analysis of 488 patients[J].J Am Coll Surg,2002,194(2):131-136.DOI:10.1016/S1072-7515(01)01159-0. [3] Gerard JP,Chapet O,Ramaioli A,et al. Long-term control of T2-T3 rectal adenocarcinoma with radiotherapy alone[J].Int J Radiat Oncol Biol Phys,2002,54(1):142-149.DOI:10.1016/S0360-3016(02)02879-1. [4] Lim L,Chao M,Shapiro J,et al. Long-term outcomes of patients with localized rectal cancer treated with chemoradiation or radiotherapy alone because of medical inoperability or patient refusal[J].Dis Colon Rectum,2007,50(12):2032-2039. [5] Wang YJ,Cummings B,Catton P,et al. Primary radical external beam radiotherapy of rectal adenocarcinoma:long term outcome of 271 patients[J].Radiother Oncol,2005,77(2):126-132.DOI:10.1016/j.radonc.2005.09.001. [6] Sprawka A,Pietrzak L,Garmol D,et al. Definitive radical external beam radiotherapy for rectal cancer:evaluation of local effectiveness and risk of late small bowel damage[J].Acta Oncol,2013,52(4):816-823.DOI:10.3109/0284186X.2012.707786. [7] Habr-Gama A,Perez RO,Wynn G,et al. Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer:characterization of clinical and endoscopic findings for standardization[J].Dis Colon Rectum,2010,53(12):1692-8169.DOI:10.1007/DCR.0b013e3181f42b89. [8] Habr-Gama A,Perez RO,Nadalin W,et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy:long-term results[J].Ann Surg,2004,240(4):711-718. [9] Habr-Gama A,Perez RO,Nadalin W,et al. Long-term results of preoperative chemoradiation for distal rectal cancer correlation between final stage and survival[J].J Gastrointest Surg,2005,9(1):90-101.DOI:10.1016/j.gassur.2004.10.010. [10] Habr-Gama A,Perez RO,Proscurshim I,et al. Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy[J].J Gastrointest Surg,2006,10(10):1319-1329.DOI:10.1016/j.gassur.2006.09.005. [11] Maas M,Beets-Tan RG,Lambregts DM,et al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer[J].J Clin Oncol,2011,29(35):4633-4640.DOI:10.1200/JCO.2011.37.7176. [12] Wynn GR,Bhasin N,Macklin CP,et al. Complete clinical response to neoadjuvant chemoradiotherapy in patients with rectal cancer:opinions of British and Irish specialists[J].Colorectal Dis,2010,12(4):327-333.DOI:10.1111/j.1463-1318.2009.01962.x.
2015, Vol. 24 
